Shared on08 Mar 25Fair value Decreased 6.09%
Unike has increased revenue growth from 8.0% to 10.0% and decreased future PE multiple from 35.0x to 30.0x.
Novo Nordisk gears up for explosive growth in weight-loss and diabetes treatments
Unike's Fair Value
DKK 1,036.18
65.6% undervalued intrinsic discount08 Mar
DKK 356.10
1Y
-61.4%7D
9.7%